• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0001558370-23-009134
    • accounts Payable Current 31,572,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 19,374,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --126,000
    • amendment Flag false
    • assets 824,767,000
    • assets Current 637,781,000
    • cash And Cash Equivalents At Carrying Value 543,484,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 549,914,000
    • cik 1,425,205
    • city Area Code 650
    • common Stock Par Or Stated Value Per Share 4.1666E-05
    • common Stock Shares Authorized 300,000,000
    • common Stock Shares Issued 224,358,979
    • common Stock Shares Outstanding 224,358,979
    • comprehensive Income Net Of Tax --106,594,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-10
    • depreciation 2,800,000
    • depreciation Depletion And Amortization 2,764,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.5
    • earnings Per Share Diluted -0.5
    • entity Address Address Line 1 825 Industrial Road, Suite 400
    • entity Address City Or Town San Carlos
    • entity Address Postal Zip Code 94,070
    • entity Address State Or Province CA
    • entity Central Index Key 1,425,205
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-36860
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name IOVANCE BIOTHERAPEUTICS, INC.
    • entity Registrant Name IOVANCE BIOTHERAPEUTICS, INC.
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 75-3254381
    • increase Decrease In Accounts Payable 3,025,000
    • irs Number 753,254,381
    • lessee Operating Lease Liability Payments Due 132,918,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 10,605,000
    • lessee Operating Lease Liability Payments Due Year Four 8,186,000
    • lessee Operating Lease Liability Payments Due Year Three 7,989,000
    • lessee Operating Lease Liability Payments Due Year Two 8,240,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 50,692,000
    • liabilities 157,886,000
    • liabilities And Stockholders Equity 824,767,000
    • liabilities Current 87,274,000
    • liabilities Noncurrent 70,612,000
    • local Phone Number 260-7120
    • net Cash Provided By Used In Financing Activities 258,172,000
    • net Cash Provided By Used In Investing Activities 153,396,000
    • net Cash Provided By Used In Operating Activities --99,800,000
    • net Income Loss --107,400,000
    • operating Expenses 110,856,000
    • operating Income Loss --110,856,000
    • operating Lease Cost 4,524,000
    • operating Lease Liability 82,226,000
    • operating Lease Liability Current 12,614,000
    • operating Lease Liability Noncurrent 69,612,000
    • operating Lease Payments 4,161,000
    • operating Lease Right Of Use Asset 70,431,000
    • other Assets Noncurrent 202,000
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 776,000
    • payments Related To Tax Withholding For Share Based Compensation 1,929,000
    • payments To Acquire Available For Sale Securities Debt 5,323,000
    • payments To Acquire Property Plant And Equipment 5,664,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 129,297,000
    • property Plant And Equipment Net 109,923,000
    • report Link https://www.sec.gov/Archives/edgar/data/1425205/000155837023009134/iova-20230331x10q_htm.xml
    • research And Development Expense 82,734,000
    • retained Earnings Accumulated Deficit --1,675,708,000
    • share Based Compensation 15,665,000
    • stockholders Equity 666,881,000
    • trading Symbol IOVA
    • update 1970-01-01
    • variable Lease Cost 1,694,000
    • weighted Average Number Of Diluted Shares Outstanding 213,694,000
    • weighted Average Number Of Shares Outstanding Basic 213,694,000
    • id REPORTED_FINANCIALS
    • key IOVA
    • subkey 10-Q
    • date 2023-05-10
    • updated 2023-05-11
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

IOVA stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001558370-23-009134
  • accounts Payable Current 31,572,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 19,374,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --126,000
  • amendment Flag false
  • assets 824,767,000
  • assets Current 637,781,000
  • cash And Cash Equivalents At Carrying Value 543,484,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 549,914,000
  • cik 1,425,205
  • city Area Code 650
  • common Stock Par Or Stated Value Per Share 4.1666E-05
  • common Stock Shares Authorized 300,000,000
  • common Stock Shares Issued 224,358,979
  • common Stock Shares Outstanding 224,358,979
  • comprehensive Income Net Of Tax --106,594,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-10
  • depreciation 2,800,000
  • depreciation Depletion And Amortization 2,764,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.5
  • earnings Per Share Diluted -0.5
  • entity Address Address Line 1 825 Industrial Road, Suite 400
  • entity Address City Or Town San Carlos
  • entity Address Postal Zip Code 94,070
  • entity Address State Or Province CA
  • entity Central Index Key 1,425,205
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-36860
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name IOVANCE BIOTHERAPEUTICS, INC.
  • entity Registrant Name IOVANCE BIOTHERAPEUTICS, INC.
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 75-3254381
  • increase Decrease In Accounts Payable 3,025,000
  • irs Number 753,254,381
  • lessee Operating Lease Liability Payments Due 132,918,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 10,605,000
  • lessee Operating Lease Liability Payments Due Year Four 8,186,000
  • lessee Operating Lease Liability Payments Due Year Three 7,989,000
  • lessee Operating Lease Liability Payments Due Year Two 8,240,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 50,692,000
  • liabilities 157,886,000
  • liabilities And Stockholders Equity 824,767,000
  • liabilities Current 87,274,000
  • liabilities Noncurrent 70,612,000
  • local Phone Number 260-7120
  • net Cash Provided By Used In Financing Activities 258,172,000
  • net Cash Provided By Used In Investing Activities 153,396,000
  • net Cash Provided By Used In Operating Activities --99,800,000
  • net Income Loss --107,400,000
  • operating Expenses 110,856,000
  • operating Income Loss --110,856,000
  • operating Lease Cost 4,524,000
  • operating Lease Liability 82,226,000
  • operating Lease Liability Current 12,614,000
  • operating Lease Liability Noncurrent 69,612,000
  • operating Lease Payments 4,161,000
  • operating Lease Right Of Use Asset 70,431,000
  • other Assets Noncurrent 202,000
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 776,000
  • payments Related To Tax Withholding For Share Based Compensation 1,929,000
  • payments To Acquire Available For Sale Securities Debt 5,323,000
  • payments To Acquire Property Plant And Equipment 5,664,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 129,297,000
  • property Plant And Equipment Net 109,923,000
  • report Link https://www.sec.gov/Archives/edgar/data/1425205/000155837023009134/iova-20230331x10q_htm.xml
  • research And Development Expense 82,734,000
  • retained Earnings Accumulated Deficit --1,675,708,000
  • share Based Compensation 15,665,000
  • stockholders Equity 666,881,000
  • trading Symbol IOVA
  • update 1970-01-01
  • variable Lease Cost 1,694,000
  • weighted Average Number Of Diluted Shares Outstanding 213,694,000
  • weighted Average Number Of Shares Outstanding Basic 213,694,000
  • id REPORTED_FINANCIALS
  • key IOVA
  • subkey 10-Q
  • date 2023-05-10
  • updated 2023-05-11